Prestige Consumer Healthcare

Corporate brand

A U.S.-based consumer healthcare company that builds and markets a portfolio of over-the-counter healthcare and personal-wellness brands.

Last updated October 30, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Prestige Consumer Healthcare Inc., historically known as Prestige Brands and Prestige Brands Holdings, is an American consumer healthcare company headquartered in Tarrytown, New York. Formed in 1996, the business has grown primarily by acquiring established over-the-counter healthcare and personal-care brands, then supporting them through marketing, product development, packaging, and expanded retail distribution. The company became publicly traded in 2005 and adopted its present corporate name in 2018. It trades on the New York Stock Exchange under the symbol PBH. The company's early history is rooted in the acquisition and consolidation of established consumer brands. Its predecessor business was formed as a joint venture involving Medtech Labs and The Shansby Group, with the aim of acquiring over-the-counter drug brands from American Home Products. The business broadened beyond medicines into personal care and household cleaning through subsequent acquisitions. A 2004 change in ownership and a series of acquisitions brought together brands and businesses that helped establish the Prestige identity. The company adopted the Prestige Brands Holdings name and entered public markets in 2005. Prestige's defining business model is portfolio stewardship: it buys recognizable brands, often from larger consumer-products or pharmaceutical companies, and seeks to give them more focused management, marketing attention, distribution, and product innovation. Its portfolio has included brands across women's health, pain relief, eye and ear care, motion sickness, sore throat relief, oral care, digestive health, pediatric remedies, wart and lice treatment, and hydration. Among its best-known current brands are Monistat, Summer's Eve, BC, Goody's, Clear Eyes, TheraTears, DenTek, Dramamine, Fleet, Chloraseptic, Luden's, Compound W, Little Remedies, Boudreaux's Butt Paste, Nix, Hydralyte, and Fess. Gaviscon is among its Canadian offerings. The composition of the portfolio changes as the company acquires brands and exits businesses that no longer fit its focus. Acquisitions have materially shaped the company's development. Early additions included Spic and Span, Prestige Brands International, Vetco and its Little Remedies products, The Doctor's oral-care line, Chore Boy, and Wartner. During a later growth phase, the company added Blacksmith Brands, Dramamine, a large group of North American consumer-health brands from GlaxoSmithKline, Australian and New Zealand healthcare businesses including Hydralyte, Insight Pharmaceuticals, and DenTek. In 2018, it sold its household-cleaning segment, including Comet, Spic and Span, Chore Boy, Chlorinol, and Cinch, and changed its corporate name from Prestige Brands Holdings to Prestige Consumer Healthcare. The move reflected a sharper emphasis on healthcare and personal wellness. Prestige subsequently added TheraTears and other consumer-health products through the acquisition of Akorn's consumer-health business in 2021. In 2026, it completed the acquisition of Breathe Right and other brands from Foundation Consumer Healthcare, extending its portfolio into nasal strips and better-breathing products. It also announced and later completed the acquisition of LaCorium Health, an Australian therapeutic skin-care business. These additions reinforced its approach of using acquisitions to enter adjacent consumer-health categories while relying on an established retail network and brand-management capabilities. The company sells primarily through retail outlets, including drug, mass-merchandise, grocery, dollar, club, convenience, and e-commerce channels. It operates in the United States and Canada, Australia, and selected international markets. Its stated approach emphasizes brand investment, consumer trust, product quality, innovation, and distribution. Prestige is not itself a single consumer product brand: it is the corporate owner and steward of a collection of separately marketed brands. Prestige has also faced legal and product-safety matters associated with its portfolio. In 2026, an appeals court affirmed a judgment for wholesale purchasers in a pricing-discrimination case involving Clear Eyes Redness Relief, while vacating and remanding the attorneys' fee award. That year, the company also voluntarily recalled a specific lot of Clear Eyes Maximum Itchy Eye Relief drops because sterility could not be assured. These matters are documented here as legal and recall developments, not as a finding of broader corporate misconduct. As of 2026, Prestige remains an active public company, with a diversified consumer healthcare portfolio and continued growth through acquisitions and brand development.

History

Prestige Consumer Healthcare traces its corporate lineage to a consumer-health business formed in 1996 as a joint venture of Medtech Labs and The Shansby Group. The original purpose was to acquire over-the-counter drug brands from American Home Products. The business's development was shaped by a recurring strategy: buying established brands from larger businesses or investors, combining them under focused ownership, and using marketing and retail distribution to sustain or expand their positions. The company later described itself as a brand builder, emphasizing that some acquired products had been treated as non-core by their former owners. The corporate structure and portfolio evolved through transactions in the early 2000s. In 2001, the portfolio expanded beyond medicines into household cleaning and personal care. In February 2004, GTCR Golder Rauner acquired the business from the owners of Medtech Labs and The Shansby Group. That year, the company acquired Spic and Span, Prestige Brands International, and Vetco. The Prestige Brands International acquisition brought the Prestige name and brands including Chloraseptic, Clear Eyes, and Murine; Vetco added Little Remedies pediatric products. The business began operating under the Prestige name following the Prestige Brands International transaction. These combinations established the platform later known as Prestige Brands Holdings. Prestige Brands Holdings became a public company in February 2005. Its early public-company portfolio continued to grow through purchases such as Chore Boy and Dental Concepts, whose products included The Doctor's NightGuard and interdental-cleaning offerings. In 2006, it acquired Wartner, an over-the-counter wart-treatment brand. The company had previously acquired Bonita Bay and Vetco, adding recognized health, personal-care, and cleaning brands. The early portfolio consequently mixed consumer healthcare with household products, rather than focusing exclusively on health. A substantial acquisition phase began around 2010. Prestige purchased Blacksmith Brands, adding PediaCare, Luden's, and Efferdent, and acquired the U.S. Dramamine business in 2011. In 2012, it completed the acquisition of a group of 17 North American consumer-health brands from GlaxoSmithKline. The GSK portfolio strengthened and diversified its healthcare presence, with brands including BC, Goody's, Beano, Ecotrin, Fiber Choice, Sominex, and Tagamet. Prestige also expanded geographically through Care Pharmaceuticals in Australia and New Zealand, including Fess and other local healthcare brands, and acquired Hydralyte in 2014. Insight Pharmaceuticals, purchased in 2014, added feminine-care and other over-the-counter products, including Monistat and Summer's Eve. The 2016 acquisition of DenTek expanded specialty oral care and added an international dimension to the business. The company continued to adjust the portfolio as its strategy narrowed. On July 2, 2018, Prestige sold the household-cleaning brands Comet, Spic and Span, Chore Boy, Chlorinol, and Cinch. This ended its household-cleaning segment and represented a strategic concentration on consumer healthcare. In August 2018, Prestige Brands Holdings changed its corporate name to Prestige Consumer Healthcare Inc. The company retained its NYSE listing and PBH ticker. The name change made the healthcare focus more explicit, while Prestige Brands remained a familiar historical name and corporate web identity. In 2021, Prestige acquired Akorn's consumer-health business, bringing TheraTears and additional products into its eye-care and consumer-health portfolio. In 2026, it completed the acquisition of Breathe Right and certain other brands from Foundation Consumer Healthcare, moving into nasal strips and better-breathing products. It also announced and completed the acquisition of LaCorium Health, an Australian therapeutic skin-care business. Both transactions illustrate the continued use of acquisitions to add adjacent categories and deepen the company's international portfolio. Prestige's operating model combines brand ownership and stewardship with manufacturing, marketing, sales, and distribution capabilities, supported by a network serving retailers and e-commerce channels. Its markets include the United States and Canada, Australia, and selected international territories. Its healthcare portfolio spans women's health, pain relief, eye and ear care, motion sickness, oral care, digestive health, sore-throat products, pediatric care, wart and lice treatments, hydration, nasal care, and skin care. The business has marketed its brands through product innovation, line extensions, advertising, retailer programs, and consumer campaigns. The company's recent public record includes legal and quality matters tied to specific products and business practices. In a case brought by wholesale purchasers concerning Clear Eyes Redness Relief, the Ninth Circuit affirmed a judgment for the purchasers under the Robinson-Patman Act in February 2026, while vacating the attorneys' fee award and remanding that issue. Separately, Prestige initiated a voluntary 2026 recall of a specified lot of Clear Eyes Maximum Itchy Eye Relief because the product's sterility could not be assured. The recall notice described potential contamination rather than confirmed contamination. As of October 2026, Prestige Consumer Healthcare remains an active, publicly traded company headquartered in Tarrytown, New York.

2026
Breathe Right and LaCorium acquisitions
[9]Breathe Right acquisition completion announcementir.prestigebrands.com
Prestige completed the acquisition of Breathe Right and certain other brands and acquired Australian therapeutic skin-care business LaCorium Health.
2021
Akorn consumer-health business acquired
[16]Akorn consumer-health business acquiredwilliamblair.com
The acquisition added TheraTears and other consumer-health products.
2018
Household-cleaning divestiture and corporate renaming
[6]2018 corporate name change announcementir.prestigebrands.com
Prestige sold its household-cleaning brands and changed its name from Prestige Brands Holdings to Prestige Consumer Healthcare.
2016
DenTek acquisition completed
[15]DenTek acquisition completedir.prestigebrands.com
DenTek strengthened Prestige's specialty oral-care platform and international reach.
2014
Insight Pharmaceuticals and Hydralyte additions
[14]Insight Pharmaceuticals and Hydralyte additionsir.prestigebrands.com
The company added feminine-care and other OTC products through Insight and broadened its Australia and New Zealand portfolio with Hydralyte.
2012
Acquisition of 17 GSK consumer-health brands
[13]Acquisition of 17 GSK consumer-health brandsir.prestigebrands.com
The acquisition materially expanded Prestige's North American over-the-counter healthcare portfolio.
2011
Dramamine acquisition
[12]Dramamine acquisitionir.prestigebrands.com
Prestige acquired the U.S. Dramamine business, adding a motion-sickness treatment brand.
2010
Blacksmith Brands acquisition
[11]Blacksmith Brands acquisitionir.prestigebrands.com
The purchase added PediaCare, Luden's, and Efferdent to the portfolio.
2005
Initial public offering
[4]Prestige Brands Holdings 2007 Form 10-Ksec.gov
Prestige Brands Holdings became publicly traded and continued acquiring consumer brands.
2004
GTCR acquires the business; Prestige identity takes shape
[4]Prestige Brands Holdings 2007 Form 10-Ksec.gov
GTCR acquired the predecessor business, and transactions involving Spic and Span, Prestige Brands International, and Vetco expanded its brand portfolio and brought the Prestige name into use.
1996
Predecessor consumer-health venture formed
[4]Prestige Brands Holdings 2007 Form 10-Ksec.gov
A joint venture involving Medtech Labs and The Shansby Group was formed to acquire over-the-counter drug brands.

Products and positioning

A portfolio-focused consumer healthcare company that acquires and develops trusted, established over-the-counter and personal-wellness brands, emphasizing focused brand management, product innovation, and broad retail distribution.

Women's health
Monistat
A women's-health brand associated with over-the-counter products for vaginal yeast infections. Prestige added the brand through its acquisition of Insight Pharmaceuticals and has included it among its core women's-health offerings.
Feminine care
Summer's Eve
A feminine-care brand with cleansing and personal-care products. It became part of Prestige's portfolio through the Insight Pharmaceuticals acquisition and remains one of the company's visible women's-health brands.
Motion-sickness treatment
Dramamine
An over-the-counter motion-sickness brand acquired by Prestige in 2011. Its portfolio includes products positioned for travel-related nausea and different consumer preferences, and the company has supported it with seasonal travel marketing and product extensions.
Eye care
Clear Eyes
An eye-care brand offering over-the-counter eye drops for symptoms including redness, dryness, and itchiness. The brand has been part of Prestige's portfolio since its early acquisition-led expansion and was involved in a 2026 recall of a specific itchy-eye product lot.
Eye care
TheraTears
An eye-care brand focused on dry-eye products, including lubricant drops and related care items. Prestige added TheraTears through its 2021 acquisition of Akorn's consumer-health business and has expanded the range with new product formats.
Specialty oral care
DenTek
A specialty oral-care brand acquired in 2016. Its products include dental picks, floss picks, interdental cleaners, mouth guards, and other accessories for home oral hygiene. The acquisition expanded Prestige's existing oral-care presence and gave it a platform with international distribution potential.
Nasal strips and breathing aids · 1990
Breathe Right
A nasal-strip brand used to support nasal airflow. Prestige acquired Breathe Right and certain other brands in 2026, entering the better-breathing category and adding a major brand outside its prior core categories.
Pain relief
BC and Goody's
Two established pain-relief brands in Prestige's portfolio. They entered the company's broader portfolio through its acquisition of North American consumer-health brands from GlaxoSmithKline and include familiar over-the-counter analgesic offerings.
Digestive health
Fleet
A consumer-health brand known for products such as enemas and glycerin suppositories. It is part of Prestige's gastrointestinal-health portfolio, alongside brands and products serving other digestive-care needs.
Sore-throat treatment
Chloraseptic
An over-the-counter sore-throat brand offering products such as sprays and lozenges. It was among the established healthcare brands associated with Prestige's early portfolio formation.
Wart treatment
Compound W
An over-the-counter wart-treatment brand offering topical products and other treatment formats. It is one of Prestige's established specialty healthcare brands.
Pediatric healthcare
Little Remedies
A pediatric consumer-health brand acquired through Prestige's purchase of Vetco. Its products are intended for common infant and children's health and personal-care needs.
Hydration and rehydration
Hydralyte
A rehydration brand acquired for Prestige's Australia and New Zealand business. Its product range includes electrolyte-based formats and complements the company's international consumer-health portfolio.
Nasal and sinus care
Fess
A nasal and sinus-care brand in Prestige's Australian portfolio, acquired through Care Pharmaceuticals. The range includes products for nasal hygiene and related respiratory-care needs.

Marketing campaigns

2026Dramamine Your Why. Your Way.
United States
A summer travel campaign focused on travelers' personal reasons for taking trips. It partnered with television personality Rob Mariano and supported the message with travel content, a consumer sweepstakes, and new travel-friendly Dramamine product formats.
Outcome. The campaign connected Dramamine's motion-sickness positioning with travel motivation and new product launches.
Source
2026DenTek Football Stress Test
United States
DenTek used football-related stress and nighttime teeth grinding as a humorous cultural hook to draw attention to oral-care products, with NFL figures involved in related campaign activity.
Outcome. The activation tied a recognizable sports-season conversation to DenTek's nighttime dental-protection products.
Source
2017Dramamine #KeepMoving
United States
Dramamine used an influencer-led summer-travel campaign to present motion-sickness treatment as a way to help families continue their travel and leisure plans. The effort featured family travel content and promoted a non-drowsy natural-ginger product.
Outcome. The campaign extended Dramamine's marketing beyond product claims by connecting the brand with summer adventures and family travel.
Source

Brand decisions

2026
Acquire Breathe Right and certain other brandsM&A
Background
Prestige sought to add a scaled brand in the adjacent better-breathing category.
Action taken
The company completed its acquisition of Breathe Right and certain other brands from Foundation Consumer Healthcare.
Aftermath
Breathe Right became Prestige's entry into nasal strips and broadened its healthcare portfolio.
Purchase price. 1.045 billion USD (Announced March 2026; acquisition completed June 15, 2026)
Source
2026
Acquire LaCorium HealthM&A
Background
Prestige sought to broaden its Australian consumer-health presence into therapeutic skin care.
Action taken
Prestige announced and completed the acquisition of LaCorium Health.
Aftermath
The acquisition expanded the company's international portfolio into therapeutic skin care.
Announced purchase price. Approximately 150 million USD (Announced May 13, 2026)
Source
2021
Acquire Akorn consumer-health assetsM&A
Background
Prestige continued expanding its consumer-health portfolio through selected acquisitions.
Action taken
The company acquired Akorn's consumer-health business.
Aftermath
The portfolio addition included TheraTears and other consumer-health products.
Source
2018
Exit household cleaning and refocus on healthcareStrategy
Background
The company stated that its evolving portfolio and growth focus were increasingly centered on consumer healthcare.
Action taken
Prestige sold Comet, Spic and Span, Chore Boy, Chlorinol, and Cinch, and changed its corporate name to Prestige Consumer Healthcare.
Aftermath
The company exited household cleaning and made its consumer-health strategy more explicit in its corporate identity.
Source
2016
Acquire DenTekM&A
Background
Prestige sought to deepen its oral-care platform and add geographic reach.
Action taken
The company completed the acquisition of DenTek, a specialty oral-care marketer and distributor.
Aftermath
DenTek became an important oral-care brand within the portfolio, alongside The Doctor's products.
Source
2014
Acquire Insight PharmaceuticalsM&A
Background
Prestige sought additional scale in women's health and adjacent OTC categories.
Action taken
Prestige completed its acquisition of Insight Pharmaceuticals.
Aftermath
The transaction added feminine-care and other consumer-health brands, including Monistat and Summer's Eve.
Source
2012
Acquire 17 North American GSK consumer-health brandsM&A
Background
Prestige aimed to concentrate on OTC healthcare and significantly increase the scale and breadth of its portfolio.
Action taken
The company acquired 17 North American consumer-health brands from GlaxoSmithKline.
Aftermath
The transaction added several established brands, including BC, Goody's, Beano, Ecotrin, Fiber Choice, Sominex, and Tagamet.
Source
2011
Acquire the U.S. Dramamine businessM&A
Background
Prestige sought to add a scaled consumer-health brand in a specialized OTC category.
Action taken
Prestige acquired the assets associated with the U.S. Dramamine business from McNeil-PPC.
Aftermath
Dramamine became one of the company's prominent motion-sickness brands and a platform for later product extensions and travel campaigns.
Source
2010
Acquire Blacksmith BrandsM&A
Background
Prestige pursued acquisitions to expand its consumer-health portfolio and add established brands from larger owners.
Action taken
The company acquired Blacksmith Brands, adding PediaCare, Luden's, and Efferdent.
Aftermath
The deal strengthened Prestige's pediatric, throat-care, and denture-care offerings and began a major acquisition phase.
Source

Recent events

2026
Prestige Consumer Healthcare completes acquisition of Breathe Right[9]Breathe Right acquisition completion announcementir.prestigebrands.com
M&A
The company completed its acquisition of Breathe Right and certain other brands from Foundation Consumer Healthcare. The deal expanded Prestige into nasal strips and better-breathing products.
2026
Prestige completes acquisition of LaCorium Health[10]LaCorium acquisition announcementir.prestigebrands.com
M&A
Prestige announced and completed the acquisition of LaCorium Health, an Australian therapeutic skin-care business, broadening its international healthcare portfolio.
2026
Ninth Circuit rules in Clear Eyes pricing-discrimination case[7]Ninth Circuit opinion in La International Corp. v. Prestige Brands Holdingscdn.ca9.uscourts.gov
Lawsuit
The Ninth Circuit affirmed the judgment for wholesale purchasers in a case alleging unlawful price discrimination involving Clear Eyes Redness Relief, but vacated the fee award and remanded for a new award.
2026
Clear Eyes Maximum Itchy Eye Relief recall[8]Clear Eyes Maximum Itchy Eye Relief recall coveragewashingtonpost.com
Recall
Prestige voluntarily recalled a specified lot of Clear Eyes Maximum Itchy Eye Relief drops after sterility could not be assured. The recall concerned potential contamination; the company said contamination was not confirmed.
2018
Prestige announces name change to Prestige Consumer Healthcare[6]2018 corporate name change announcementir.prestigebrands.com
Other
The company changed its name from Prestige Brands Holdings, Inc. to Prestige Consumer Healthcare Inc., describing the new name as a reflection of its expanding consumer healthcare business and portfolio.
2018
Prestige sells its household-cleaning segment[19]Exit household cleaning and refocus on healthcaresec.gov
M&A · strategy
Prestige sold the Comet, Spic and Span, Chore Boy, Chlorinol, and Cinch brands, exiting household cleaning to focus more squarely on healthcare.
2016
Prestige completes acquisition of DenTek[15]DenTek acquisition completedir.prestigebrands.com
M&A
The acquisition added a specialty oral-care platform and broadened the company's geographic reach.
2014
Prestige acquires Insight Pharmaceuticals[14]Insight Pharmaceuticals and Hydralyte additionsir.prestigebrands.com
M&A
The acquisition added feminine-care and other over-the-counter healthcare products to Prestige's portfolio.
2011
Prestige acquires Dramamine[12]Dramamine acquisitionir.prestigebrands.com
M&A
Prestige acquired the U.S. Dramamine business, adding a leading motion-sickness treatment brand to its portfolio.

Sources19 sources

Cite this profile: Cite the canonical profile. /brand-wiki/prestige-brands · Editorial policy · How profiles are compiled